Skip to content
English
  • There are no suggestions because the search field is empty.

Can SAM EEG Be Used Alongside Spravato® Treatment?

Yes. SAM EEG can be used alongside Spravato® (esketamine) treatment as part of a broader clinical assessment process. SAM EEG provides structured EEG-based information and EEG-derived metrics for clinician review, which can be considered together with symptoms, clinical history, patient-reported outcomes, observations, and other relevant information when making care decisions. SAM is designed to support EEG recording and analysis and generate a structured EEG report, while interpretation and treatment decisions remain the responsibility of the treating clinician.

 How SAM EEG Fits into a Spravato Workflow?

Clinics that offer Spravato treatment often use multiple sources of information to understand a patient's condition and monitor progress over time. SAM EEG can provide an additional EEG-based view of brain activity that clinicians may review as part of their overall assessment. The information generated by SAM is intended to complement, not replace, clinical evaluation and judgment. 

SAM EEG is designed for practical use in real-world psychiatric and neuromodulation workflows, making it suitable for integration into existing clinical processes where objective measurements may be valuable.

Does SAM EEG Determine Whether a Patient Should Receive Spravato?

No. SAM EEG does not diagnose conditions, select treatments, or provide automated treatment recommendations. The report presents structured EEG-based information and EEG-derived metrics in a format that clinicians can review and interpret within the context of the patient's overall clinical picture. Treatment selection, modification, and ongoing management remain clinician-led decisions.

Can SAM EEG Be Used Before, During, or After Treatment?

The appropriate timing and use of EEG assessments are determined by the treating clinician and the clinic's workflow. SAM EEG provides EEG-based information that clinicians can review whenever they believe it may contribute to the assessment process. The SAM documentation does not prescribe specific treatment protocols or clinical decision pathways.